Simulations Plus, Inc. (SLP)
USD 24.41
(-4.96%)
USD 24.41
(-4.96%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 43.15 Million USD | -10.0% |
| 2023 | 47.94 Million USD | 11.29% |
| 2022 | 43.08 Million USD | 20.12% |
| 2021 | 35.86 Million USD | 15.92% |
| 2020 | 30.93 Million USD | 24.03% |
| 2019 | 24.94 Million USD | 15.1% |
| 2018 | 21.67 Million USD | 21.55% |
| 2017 | 17.83 Million USD | 16.0% |
| 2016 | 15.37 Million USD | 9.8% |
| 2015 | 13.99 Million USD | 42.38% |
| 2014 | 9.83 Million USD | 16.71% |
| 2013 | 8.42 Million USD | 6.12% |
| 2012 | 7.93 Million USD | -10.21% |
| 2011 | 8.84 Million USD | 8.26% |
| 2010 | 8.16 Million USD | 19.71% |
| 2009 | 6.82 Million USD | -0.67% |
| 2008 | 6.86 Million USD | 1.36% |
| 2007 | 6.77 Million USD | 59.4% |
| 2006 | 4.25 Million USD | 31.01% |
| 2005 | 3.24 Million USD | -11.1% |
| 2004 | 3.64 Million USD | -7.53% |
| 2003 | 3.94 Million USD | 32.11% |
| 2002 | 2.98 Million USD | 27.03% |
| 2001 | 2.35 Million USD | -4.68% |
| 2000 | 2.46 Million USD | 35.69% |
| 1999 | 1.81 Million USD | 104.47% |
| 1998 | 889.25 Thousand USD | -28.33% |
| 1997 | 1.24 Million USD | -11.37% |
| 1996 | 1.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 9.84 Million USD | -19.61% |
| 2024 Q3 | 13.25 Million USD | 0.27% |
| 2024 Q4 | 6.8 Million USD | -48.52% |
| 2024 Q2 | 13.22 Million USD | 34.25% |
| 2023 Q4 | 12.25 Million USD | -7.7% |
| 2023 Q1 | 9.29 Million USD | 2.61% |
| 2023 FY | 47.94 Million USD | 11.29% |
| 2023 Q2 | 13.13 Million USD | 41.29% |
| 2023 Q3 | 13.27 Million USD | 1.09% |
| 2022 Q1 | 9.66 Million USD | 36.92% |
| 2022 FY | 43.08 Million USD | 20.12% |
| 2022 Q4 | 9.05 Million USD | -26.96% |
| 2022 Q3 | 12.4 Million USD | 3.63% |
| 2022 Q2 | 11.96 Million USD | 23.86% |
| 2021 Q4 | 7.05 Million USD | -31.54% |
| 2021 Q1 | 8.26 Million USD | 20.43% |
| 2021 Q3 | 10.3 Million USD | 0.68% |
| 2021 Q2 | 10.23 Million USD | 23.8% |
| 2021 FY | 35.86 Million USD | 15.92% |
| 2020 Q4 | 6.86 Million USD | -28.73% |
| 2020 FY | 30.93 Million USD | 24.03% |
| 2020 Q1 | 6.75 Million USD | 17.84% |
| 2020 Q2 | 7.68 Million USD | 13.69% |
| 2020 Q3 | 9.63 Million USD | 25.37% |
| 2019 Q1 | 5.33 Million USD | 16.81% |
| 2019 Q2 | 6.26 Million USD | 17.4% |
| 2019 Q3 | 7.61 Million USD | 21.53% |
| 2019 Q4 | 5.73 Million USD | -24.66% |
| 2019 FY | 24.94 Million USD | 15.1% |
| 2018 Q4 | 4.56 Million USD | -30.05% |
| 2018 Q2 | 5.24 Million USD | -1.72% |
| 2018 FY | 21.67 Million USD | 21.55% |
| 2018 Q1 | 5.33 Million USD | 24.24% |
| 2018 Q3 | 6.53 Million USD | 24.59% |
| 2017 Q3 | 5.3 Million USD | 27.75% |
| 2017 Q2 | 4.15 Million USD | 1.71% |
| 2017 Q1 | 4.08 Million USD | 40.86% |
| 2017 FY | 17.83 Million USD | 16.0% |
| 2017 Q4 | 4.29 Million USD | -19.06% |
| 2016 FY | 15.37 Million USD | 9.8% |
| 2016 Q1 | 3.75 Million USD | 42.53% |
| 2016 Q2 | 3.89 Million USD | 3.85% |
| 2016 Q4 | 2.89 Million USD | -39.84% |
| 2016 Q3 | 4.81 Million USD | 23.52% |
| 2015 Q2 | 3.44 Million USD | 11.66% |
| 2015 Q1 | 3.08 Million USD | 100.94% |
| 2015 FY | 13.99 Million USD | 42.38% |
| 2015 Q3 | 4.82 Million USD | 39.96% |
| 2015 Q4 | 2.63 Million USD | -45.41% |
| 2014 Q3 | 3.51 Million USD | 35.67% |
| 2014 FY | 9.83 Million USD | 16.71% |
| 2014 Q1 | 2.19 Million USD | 74.18% |
| 2014 Q2 | 2.58 Million USD | 18.09% |
| 2014 Q4 | 1.53 Million USD | -56.25% |
| 2013 Q3 | 2.64 Million USD | 0.9% |
| 2013 FY | 8.42 Million USD | 6.12% |
| 2013 Q1 | 1.9 Million USD | 44.57% |
| 2013 Q2 | 2.61 Million USD | 37.63% |
| 2013 Q4 | 1.25 Million USD | -52.37% |
| 2012 Q3 | 2.33 Million USD | -2.46% |
| 2012 FY | 7.93 Million USD | -10.21% |
| 2012 Q1 | 1.89 Million USD | 22.49% |
| 2012 Q2 | 2.39 Million USD | 26.22% |
| 2012 Q4 | 1.31 Million USD | -43.59% |
| 2011 Q1 | 2.07 Million USD | 24.18% |
| 2011 Q3 | 2.62 Million USD | 0.84% |
| 2011 Q2 | 2.6 Million USD | 25.61% |
| 2011 Q4 | 1.54 Million USD | -40.99% |
| 2011 FY | 8.84 Million USD | 8.26% |
| 2010 FY | 8.16 Million USD | 19.71% |
| 2010 Q4 | 1.66 Million USD | -31.1% |
| 2010 Q3 | 2.41 Million USD | 7.57% |
| 2010 Q2 | 2.24 Million USD | 22.9% |
| 2010 Q1 | 1.83 Million USD | 60.46% |
| 2009 Q1 | 1.6 Million USD | 23.48% |
| 2009 Q4 | 1.14 Million USD | -47.45% |
| 2009 Q3 | 2.17 Million USD | 14.01% |
| 2009 FY | 6.82 Million USD | -0.67% |
| 2009 Q2 | 1.9 Million USD | 18.48% |
| 2008 FY | 6.86 Million USD | 1.36% |
| 2008 Q4 | 1.3 Million USD | -44.5% |
| 2008 Q3 | 2.34 Million USD | 35.98% |
| 2008 Q2 | 1.72 Million USD | 15.11% |
| 2008 Q1 | 1.49 Million USD | -12.06% |
| 2007 Q2 | 1.97 Million USD | 94.75% |
| 2007 Q3 | 2.08 Million USD | 5.25% |
| 2007 Q4 | 1.7 Million USD | -18.13% |
| 2007 FY | 6.77 Million USD | 59.4% |
| 2007 Q1 | 1.01 Million USD | -22.75% |
| 2006 Q1 | 487.21 Thousand USD | -42.2% |
| 2006 FY | 4.25 Million USD | 31.01% |
| 2006 Q3 | 1.35 Million USD | 23.76% |
| 2006 Q2 | 1.09 Million USD | 124.69% |
| 2006 Q4 | 1.31 Million USD | -3.01% |
| 2005 Q4 | 842.95 Thousand USD | -15.38% |
| 2005 FY | 3.24 Million USD | -11.1% |
| 2005 Q2 | 660.98 Thousand USD | -11.2% |
| 2005 Q3 | 996.17 Thousand USD | 50.71% |
| 2005 Q1 | 744.34 Thousand USD | -32.52% |
| 2004 Q1 | 786.98 Thousand USD | -51.05% |
| 2004 Q4 | 1.1 Million USD | 29.7% |
| 2004 Q3 | 850.48 Thousand USD | -6.43% |
| 2004 Q2 | 908.96 Thousand USD | 15.5% |
| 2004 FY | 3.64 Million USD | -7.53% |
| 2003 Q2 | 748.23 Thousand USD | 0.47% |
| 2003 Q1 | 744.71 Thousand USD | -10.53% |
| 2003 Q3 | 846.29 Thousand USD | 13.11% |
| 2003 Q4 | 1.6 Million USD | 89.96% |
| 2003 FY | 3.94 Million USD | 32.11% |
| 2002 Q4 | 832.33 Thousand USD | 11.44% |
| 2002 FY | 2.98 Million USD | 27.03% |
| 2002 Q3 | 746.9 Thousand USD | -3.44% |
| 2002 Q2 | 773.52 Thousand USD | 21.86% |
| 2002 Q1 | 634.74 Thousand USD | 22.84% |
| 2001 FY | 2.35 Million USD | -4.68% |
| 2001 Q4 | 516.71 Thousand USD | -12.37% |
| 2001 Q3 | 589.65 Thousand USD | -1.32% |
| 2001 Q2 | 597.56 Thousand USD | -7.76% |
| 2001 Q1 | 647.82 Thousand USD | 9.77% |
| 2000 FY | 2.46 Million USD | 35.69% |
| 2000 Q1 | 623.94 Thousand USD | 96.03% |
| 2000 Q4 | 590.15 Thousand USD | 22.41% |
| 2000 Q3 | 482.09 Thousand USD | -37.48% |
| 2000 Q2 | 771.11 Thousand USD | 23.59% |
| 1999 Q2 | 400 Thousand USD | -33.33% |
| 1999 Q1 | 600 Thousand USD | 641.78% |
| 1999 FY | 1.81 Million USD | 104.47% |
| 1999 Q3 | 600 Thousand USD | 50.0% |
| 1999 Q4 | 318.29 Thousand USD | -46.95% |
| 1998 Q2 | 300 Thousand USD | 0.0% |
| 1998 FY | 889.25 Thousand USD | -28.33% |
| 1998 Q3 | 300 Thousand USD | 0.0% |
| 1998 Q4 | -110.74 Thousand USD | -136.92% |
| 1998 Q1 | 300 Thousand USD | 113.13% |
| 1997 FY | 1.24 Million USD | -11.37% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | -50.0% |
| 1997 Q4 | 140.75 Thousand USD | -53.08% |
| 1997 Q1 | 600 Thousand USD | 0.0% |
| 1996 FY | 1.4 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CareCloud, Inc. | 46.24 Million USD | 6.684% |
| Augmedix, Inc. | 21.52 Million USD | -100.46% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 96.99% |
| CareCloud, Inc. | 46.24 Million USD | 6.684% |
| HealthEquity, Inc. | 622.63 Million USD | 93.07% |
| iCoreConnect Inc. | 6.12 Million USD | -604.801% |
| Inovalon Holdings, Inc. | 499.7 Million USD | 91.365% |
| Nutex Health, Inc. | 34.77 Million USD | -24.089% |
| Omnicell, Inc. | 499.92 Million USD | 91.369% |
| OneMedNet Corporation | -127.9 Thousand USD | 33838.077% |
| Progyny, Inc. | 238.79 Million USD | 81.93% |
| Renalytix Plc | 156 Thousand USD | -27560.897% |
| Schrödinger, Inc. | 140.69 Million USD | 69.329% |
| SOPHiA GENETICS SA | 42.91 Million USD | -0.555% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | -273.828% |
| Ontrak, Inc. | 8.8 Million USD | -390.352% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 99.455% |
| Sharecare, Inc. | 129.49 Million USD | 66.679% |
| Aclarion, Inc. | -324.00 USD | 13318309.877% |
| CareMax, Inc. | 13.9 Million USD | -210.417% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -72058.863% |
| Forian Inc. | 15 Million USD | -187.591% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -72058.863% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | 28.82% |
| SCWorx Corp. | 1.26 Million USD | -3300.185% |
| Minerva Surgical, Inc. | 27.24 Million USD | -58.399% |
| Definitive Healthcare Corp. | 203.93 Million USD | 78.841% |
| 10x Genomics, Inc. | 409.31 Million USD | 89.458% |
| Zhongchao Inc. | 8.51 Million USD | -406.932% |
| Accolade, Inc. | 192.06 Million USD | 77.533% |
| MSP Recovery, Inc. | 5.56 Million USD | -676.097% |
| R1 RCM Inc. | 484.5 Million USD | 91.094% |
| Spok Holdings, Inc. | 112.2 Million USD | 61.543% |
| Privia Health Group, Inc. | 161.5 Million USD | 73.281% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -5024.365% |
| TruBridge, Inc. | 163.56 Million USD | 73.619% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 96.99% |
| Sharecare, Inc. | 129.49 Million USD | 66.679% |
| Health Catalyst, Inc. | 131.83 Million USD | 67.268% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 93.685% |
| Premier, Inc. | 840.73 Million USD | 94.867% |
| HealthStream, Inc. | 184.04 Million USD | 76.554% |
| Certara, Inc. | 213.31 Million USD | 79.771% |
| GeneDx Holdings Corp. | 60.62 Million USD | 28.82% |
| Ontrak, Inc. | 8.8 Million USD | -390.352% |
| SHL Telemedicine Ltd. | 25.26 Million USD | -70.821% |
| CareCloud, Inc. | 46.24 Million USD | 6.684% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -5024.365% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -9900.209% |
| CareMax, Inc. | 13.9 Million USD | -210.417% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -536.727% |
| National Research Corporation | 86.66 Million USD | 50.21% |
| Aclarion, Inc. | -324.00 USD | 13318309.877% |
| OptimizeRx Corporation | 42.89 Million USD | -0.585% |